We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$97.1B
AUM Growth
+$3.73B
Cap. Flow
-$572M
Cap. Flow %
-0.59%
Top 10 Hldgs %
29.21%
Holding
7,380
New
424
Increased
3,249
Reduced
2,816
Closed
405

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$637M
2
WY icon
Weyerhaeuser
WY
+$340M
3
IQV icon
IQVIA
IQV
+$132M
4
HAL icon
Halliburton
HAL
+$123M
5
DOV icon
Dover
DOV
+$112M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Healthcare 5.12%
3 Financials 4.53%
4 Consumer Discretionary 4.09%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
4301
PUT
Molina Healthcare
MOH
$10B
$213K ﹤0.01%
3,100
+600
+24% +$39.1K
WEN icon
4302
CALL
Wendy's
WEN
$1.41B
$213K ﹤0.01%
13,700
+7,100
+108% +$109K
ECOL
4303
DELISTED
US Ecology, Inc.
ECOL
$213K ﹤0.01%
3,961
+1,367
+53% +$69.5K
MXWL
4304
PUT
DELISTED
Maxwell Technologies Inc
MXWL
$213K ﹤0.01%
41,600
-11,200
-21% -$63.9K
NXTM
4305
PUT
DELISTED
NxStage Medical Inc.
NXTM
$213K ﹤0.01%
+7,700
New +$205K
AWR icon
4306
American States Water
AWR
$3.36B
$212K ﹤0.01%
4,293
-3,598
-46% -$178K
CNMD icon
4307
CONMED
CNMD
$1.49B
$212K ﹤0.01%
4,043
-106
-3% -$5.32K
PBA icon
4308
Pembina Pipeline
PBA
$27.9B
$212K ﹤0.01%
6,010
+1,765
+42% +$58.9K
SQM icon
4309
CALL
Sociedad Química y Minera de Chile
SQM
$20.7B
$212K ﹤0.01%
+3,800
New +$171K
COUP
4310
DELISTED
Coupa Software Incorporated
COUP
$212K ﹤0.01%
6,818
+6,453
+1,768% +$197K
CRSP icon
4311
CRISPR Therapeutics
CRSP
$4.99B
$211K ﹤0.01%
+11,864
New +$215K
PTLA
4312
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$211K ﹤0.01%
3,900
-300
-7% -$17.6K
WP
4313
CALL
DELISTED
Worldpay, Inc.
WP
$211K ﹤0.01%
3,000
+2,200
+275% +$150K
APLP
4314
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$211K ﹤0.01%
14,766
-19,512
-57% -$274K
SCLN
4315
CALL
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$211K ﹤0.01%
18,800
-100
-0.5% -$1.1K
AAWW
4316
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$211K ﹤0.01%
3,200
-1,300
-29% -$81.3K
MOD icon
4317
Modine Manufacturing
MOD
$10.2B
$210K ﹤0.01%
10,926
+4,117
+60% +$69K
RWT
4318
Redwood Trust
RWT
$573M
$210K ﹤0.01%
12,863
+4,107
+47% +$68.8K
BCPC
4319
Balchem Corp
BCPC
$5.75B
$210K ﹤0.01%
2,584
-5,051
-66% -$388K
NVRI icon
4320
CALL
Enviri
NVRI
$630M
$209K ﹤0.01%
10,000
+2,600
+35% +$44.4K
OTIC
4321
PUT
DELISTED
Otonomy, Inc.
OTIC
$209K ﹤0.01%
+64,400
New +$868K
LXFT
4322
DELISTED
Luxoft Holding, Inc.
LXFT
$209K ﹤0.01%
4,361
-14,371
-77% -$781K
HI
4323
DELISTED
Hillenbrand
HI
$208K ﹤0.01%
5,343
-8,854
-62% -$321K
NVS icon
4324
Novartis
NVS
$293B
$208K ﹤0.01%
2,700
+558
+26% +$42.1K
TSEM icon
4325
Tower Semiconductor
TSEM
$25.4B
$208K ﹤0.01%
6,736
-87,223
-93% -$2.38M

Similar funds

Barclays's Q3 2017 Portfolio in Review

As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
  • Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
  • Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
  • Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
  • Barclays opened 424 new positions and closed 405 in Q3 2017.
  • Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.